$3,418.67 travel Payment -- Gilead Sciences to Dr. David Kim

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Gilead Sciences made a $3.4K travel payment to David Kim, a Infectious Disease specialist in Akron, OH. The payment was associated with Entresto. The payment of $3,418.67 to Dr. David Kim from Gilead Sciences was for travel and lodging related to Entresto. This payment occurred on July 4, 2025, and was made by Gilead Sciences, a major pharmaceutical company. The payment was associated with the drug Entresto, indicating a potential educational or promotional purpose.

Patient Guidance: What This Payment Means for You

Patients should be aware that their doctor may receive payments from pharmaceutical companies for travel and lodging, which could be related to educational events or product discussions. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

While travel and lodging payments are common in the pharmaceutical industry, the amount and specific context should be considered in relation to typical educational events for Infectious Disease specialists.

Regulatory Context: Sunshine Act Requirements

Payments made by pharmaceutical companies to physicians are subject to disclosure under the Sunshine Act (part of the Affordable Care Act) to promote transparency in healthcare.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• physician-compensation
• travel-expenses
• gilead-sciences
• entresto
• infectious-disease
• cms-open-payments

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $3.4K payment for?

This was a travel payment of $3.4K from Gilead Sciences to David Kim, categorized as "Travel and Lodging". It was associated with Entresto. The payment was reported under the Sunshine Act (CMS Open Payments).

Does David Kim accept pharmaceutical money?

Yes, David Kim received this $3.4K payment from Gilead Sciences. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view David Kim's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $3.4K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Infectious Disease?

To compare this payment against Infectious Disease averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Infectious Disease physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about David Kim's relationship with Gilead Sciences?

The payment amount is substantial for travel and lodging, suggesting a multi-day event or significant travel distance. This $3.4K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Infectious Disease?

The payment was made by Gilead Sciences, a company with a broad portfolio of medications.

What should patients do after learning about this payment?

Patients should be aware that their doctor may receive payments from pharmaceutical companies for travel and lodging, which could be related to educational events or product discussions.

What else should I know about this travel payment?

The specific drug, Entresto, is a cardiovascular medication, which may or may not align with Dr. Kim's primary specialty.

Related Reports

• View Dr. David Kim's full payment report
• Gilead Sciences full spending report
• Browse all Infectious Disease payments
• Browse all payments in Ohio
• Search for other payments